AMEL - Observational study of the management of metastatic melanoma in France

Head :
Godard Chloé, MSD France

Last update : 10/19/2017 | Version : 1 | ID : 73340

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Observational study of the management of metastatic melanoma in France
Sign or acronym AMEL
General Aspects
Medical area Cancer research
Pathology (details) metastatic melanoma
Scientific investigator(s) (Contact)
Name of the director Godard
Surname Chloé
Address 34 avenue Léonard de Vinci
92418 Courbevoie cedex
Email chloe.godard@merck.com
Unit MSD France
Collaborations
Funding
Funding status Private
Details MSD France
Governance of the database
Sponsor(s) or organisation(s) responsible MSD France
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Longitudinal study (except cohorts)
Database objective
Main objective Describe the sociodemographic and clinical profile of patients with metastatic melanoma as well as their therapeutic management
Inclusion criteria Inclusion criteria:
• History of histopathologically confirmed diagnosis of cutaneous melanoma
• Unresectable stage III (per treating physician) or stage IV melanoma according to AJCC (2009) classification at diagnosis or upon progression following diagnosis
• Subject’s index date is between 1 January 2012 and 31 October 2012.
• Age >= 18 years at the index date
• Access to the complete records from the index date until the end of the data extraction period or death whichever is earlier
Non-inclusion criteria:
• Patients with primary non-cutaneous melanoma including primary ocular melanoma
• Patients with an index date before 1 January 2012 and 31 October 2012.
• Patients with resectable melanoma who have not relapsed
Population type
Age Adulthood (19 to 24 years)
Adulthood (25 to 44 years)
Adulthood (45 to 64 years)
Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Pathology C00-C97 - Malignant neoplasms
Gender Male
Woman
Geography area National
Detail of the geography area no information about the individual
Data collection
Dates
Size of the database
Size of the database (number of individuals) < 500 individuals
Details of the number of individuals 271 patients included
Data
Database activity Data collection completed
Type of data collected Clinical data
Administrative data
Cost data
Clinical data (detail) Direct physical measures
Presence of a biobank No
Procedures
Participant monitoring No
Followed pathology
Links to administrative sources No
Promotion and access
Promotion
Access
Terms of data access (charter for data provision, format of data, availability delay) No data access charter
Access to aggregated data Access not yet planned
Access to individual data No access

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05